135 related articles for article (PubMed ID: 38794899)
1. Turmeric and curcumin as adjuncts in controlling Helicobacter pylori-associated diseases: a narrative review.
Boyanova L; Medeiros J; Yordanov D; Gergova R; Markovska R
Lett Appl Microbiol; 2024 Jun; 77(6):. PubMed ID: 38794899
[TBL] [Abstract][Full Text] [Related]
2. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.
Sarkar A; De R; Mukhopadhyay AK
World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412
[TBL] [Abstract][Full Text] [Related]
3. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?
Di Mario F; Cavallaro LG; Nouvenne A; Stefani N; Cavestro GM; Iori V; Maino M; Comparato G; Fanigliulo L; Morana E; Pilotto A; Martelli L; Martelli M; Leandro G; Franzè A
Helicobacter; 2007 Jun; 12(3):238-43. PubMed ID: 17493004
[TBL] [Abstract][Full Text] [Related]
4. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen.
Mahady GB; Pendland SL; Yun G; Lu ZZ
Anticancer Res; 2002; 22(6C):4179-81. PubMed ID: 12553052
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice.
De R; Kundu P; Swarnakar S; Ramamurthy T; Chowdhury A; Nair GB; Mukhopadhyay AK
Antimicrob Agents Chemother; 2009 Apr; 53(4):1592-7. PubMed ID: 19204190
[TBL] [Abstract][Full Text] [Related]
6. Blue light emitting diodes enhance the antivirulence effects of Curcumin against
Darmani H; Smadi EAM; Bataineh SMB
J Med Microbiol; 2020 Apr; 69(4):617-624. PubMed ID: 32100708
[No Abstract] [Full Text] [Related]
7. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases.
Mohammadi A; Khanbabaei H; Zandi F; Ahmadi A; Haftcheshmeh SM; Johnston TP; Sahebkar A
Microb Pathog; 2022 May; 166():105552. PubMed ID: 35469998
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.
Fontes LES; Martimbianco ALC; Zanin C; Riera R
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012357. PubMed ID: 30746681
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal microbiome and
Sitkin S; Lazebnik L; Avalueva E; Kononova S; Vakhitov T
World J Gastroenterol; 2022 Feb; 28(7):766-774. PubMed ID: 35317277
[No Abstract] [Full Text] [Related]
10. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells.
Foryst-Ludwig A; Neumann M; Schneider-Brachert W; Naumann M
Biochem Biophys Res Commun; 2004 Apr; 316(4):1065-72. PubMed ID: 15044093
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study.
Kakiuchi T; Yamamoto K; Imamura I; Hashiguchi K; Kawakubo H; Yamaguchi D; Fujioka Y; Okuda M
Sci Rep; 2021 Jan; 11(1):755. PubMed ID: 33436953
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
[TBL] [Abstract][Full Text] [Related]
13. Medicinal plant activity on Helicobacter pylori related diseases.
Wang YC
World J Gastroenterol; 2014 Aug; 20(30):10368-82. PubMed ID: 25132753
[TBL] [Abstract][Full Text] [Related]
14. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
[TBL] [Abstract][Full Text] [Related]
15. High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment.
Zhang M
World J Gastroenterol; 2015 Dec; 21(48):13432-7. PubMed ID: 26730153
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Koosirirat C; Linpisarn S; Changsom D; Chawansuntati K; Wipasa J
Int Immunopharmacol; 2010 Jul; 10(7):815-8. PubMed ID: 20438867
[TBL] [Abstract][Full Text] [Related]
17. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
18. Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial.
Kakiuchi T; Mizoe A; Yamamoto K; Imamura I; Hashiguchi K; Kawakubo H; Yamaguchi D; Fujioka Y; Nakayama A; Okuda M; Matsuo M
Helicobacter; 2020 Jun; 25(3):e12690. PubMed ID: 32207209
[TBL] [Abstract][Full Text] [Related]
19. The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota.
Cui MY; Cui ZY; Zhao MQ; Zhang MJ; Jiang QL; Wang JJ; Lu LG; Lu YY
BMC Microbiol; 2022 Dec; 22(1):321. PubMed ID: 36581836
[TBL] [Abstract][Full Text] [Related]
20. Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections.
Mosallam FM; Bendary MM; Elshimy R; El-Batal AI
World J Microbiol Biotechnol; 2023 Sep; 39(12):324. PubMed ID: 37773301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
